LCI GETTING CONFIRMED WITH DIFFERENT MGs.. $4.00
Lannett receives FDA approval for Loxapine capsules (LCI) 3.94 : Co announced that it it has received approval from the FDA for its Abbreviated New Drug Application of Loxapine Capsules, 5 mg, 10 mg, 25 mg and 50 mg, which are therapeutically equivalent to the reference listed drug, Loxitane Capsules, 5 mg, 10 mg, 25 mg and 50 mg from Watson Pharmaceuticals (WPI).